Cargando…
Immunogenicity of a Candidate DTacP-sIPV Combined Vaccine and Its Protection Efficacy against Pertussis in a Rhesus Macaque Model
The research and development of a pertussis-combined vaccine using a novel inactivated poliovirus vaccine made from the Sabin strain (sIPV) is of great significance in the polio eradication project and to address the recent resurge in pertussis. In the present study, we compared the immunogenicity a...
Autores principales: | Wang, Xiaoyu, Gao, Na, Wen, Jiana, Li, Jingyan, Ma, Yan, Sun, Mingbo, Liang, Jiangli, Shi, Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8779802/ https://www.ncbi.nlm.nih.gov/pubmed/35062708 http://dx.doi.org/10.3390/vaccines10010047 |
Ejemplares similares
-
Safety and immunogenicity of a combined DTacP-sIPV-Hib vaccine in animal models
por: Zhang, Yuntao, et al.
Publicado: (2022) -
Dose-Sparing Intradermal DTaP-sIPV Immunization With a Hollow Microneedle Leads to Superior Immune Responses
por: Zuo, Weilun, et al.
Publicado: (2021) -
Potency of the Sabin inactivated poliovirus vaccine (sIPV) after exposure to freezing temperatures in cold chains
por: Cai, Wei, et al.
Publicado: (2020) -
Infant rhesus macaques as a non-human primate model of Bordetella pertussis infection
por: Jiang, Wenwen, et al.
Publicado: (2021) -
Analysis of the dose-sparing effect of adjuvanted Sabin-inactivated poliovirus vaccine (sIPV)
por: Li, Zhuofan, et al.
Publicado: (2018)